BACKGROUND: Severe traumatic injury is associated with bone marrow dysfunction that manifests as impaired erythropoiesis and prolonged hematopoietic progenitor cell (HPC) mobilization from the bone marrow. Extramedullary erythropoiesis, the development of red blood cells outside the bone marrow, has not been studied after severe injury and critical illness. This study examined the influence of lung contusion/hemorrhagic shock (LCHS) followed by chronic stress (CS) on the rodent spleen and to investigate the involvement of the splenic erythropoietin (EPO)/ EPO receptor and BMP4 signaling.
A fter severe trauma, there a norepinephrine-mediated hypercatecholamine state that is associated with bone marrow dysfunction due to both prolonged hematopoietic progenitor cell (HPC) mobilization and decreased growth of bone marrow erythroid progenitor cells. [1] [2] [3] [4] [5] [6] Previous work has demonstrated that HPC mobilization to the peripheral blood can persist up to 7 days in rodents and up to fourteen days in severely injured humans. 3, 4 Injury-associated anemia is multifactorial in nature and likely secondary to a combination of acute blood loss, multiple phlebotomies, nutritional abnormalities, and bone marrow dysfunction, resulting in inadequate production of erythrocytes. [5] [6] [7] [8] Although this anemia appears early after traumatic injury, it often persists for months regardless of blood transfusions. [5] [6] [7] [8] Previously, we have demonstrated that a rodent model of lung contusion, hemorrhagic shock, and chronic stress (CS) mimics what is seen in critical illness after injury. 4, 6 The addition of CS to lung contusion and hemorrhagic shock leads to prolonged HPC mobilization and decreased bone marrow erythroid progenitor cell growth and is associated with a persistent injuryassociated anemia. 4, 6 In the bone marrow, erythropoiesis produces erythrocytes at a steady state; however, at times of stress, erythropoiesis can occur in other organs that were once embryonic sites of erythropoiesis such as the liver and spleen. [9] [10] [11] Erythropoiesis that occurs outside of the bone marrow is known as extramedullary erythropoiesis. 12 Various hematopoietic stressors, including infection, anemia, pregnancy, and myocardial infarction, can all trigger extramedullary erythropoiesis or stress erythropoiesis. [13] [14] [15] [16] [17] [18] [19] [20] [21] In the presence of anemia, hypoxia induces erythropoietin (EPO) production in the kidney, which can lead to extramedullary erythropoiesis in the spleen. 9, 12, 20, 21 The adult spleen contains a unique microenvironment that is favorable for the rapid expansion of erythroid progenitors in response to stressful stimuli. 20, 21 In the spleen, extramedullary erythropoiesis resulted in accelerated red blood cell production in an attempt to keep up with the demand. 22 Aside from occurring in different organs, homeostatic erythropoiesis that occurs in the bone marrow and extramedullary erythropoiesis that occurs in the spleen also differ in the signals to which they respond. Extramedullary erythropoiesis in the spleen uniquely requires bone morphogenetic protein 4 (BMP4) to expand erythroid progenitor cells into mature erythroblasts. 20 Extramedullary erythropoiesis has been well studied after phenylhydralazine-induced anemia in mice. 9, 10, [20] [21] [22] [23] However, the erythropoietic effects of severe trauma and CS on the spleen have not been previously reported. Therefore, this study sought to examine the influence of lung contusion/hemorrhagic shock (LCHS) followed by CS on the rodent spleen and to investigate the involvement of the splenic EPO/EPO receptor and BMP4 signaling.
MATERIALS AND METHODS

Rodents
Male Sprague-Dawley rats (Charles River, Wilmington, MA), weighing 275 g to 300 g were housed in pairs with free access to food and water during daily night/day cycles of 12 hours each. Female animals were excluded due to estrous cycle variability and its impact after hemorrhagic shock. The animal protocol was approved by the University of Florida Institutional Animal Care and Use Committee.
Experimental Rodent Models
Rodents were randomly assigned into one of the three groups (n = 6/group): (1) naive control, (2) lung contusion followed by hemorrhagic shock (LCHS), (3) LCHS followed by daily CS (LCHS/CS). Naïve rodents underwent daily handling. All rodents were weighed daily using a Kent Scientific animal weighing scale (Torrington, CT). Rodents who underwent LCHS and LCHS/CS were sacrificed after 7 days. Immediately after sacrifice, spleens were harvested and weighed using a Mettler Toledo balance (Columbus, OH). Spleen and peripheral blood were collected and stored at −80°C freezer.
Lung Contusion and Hemorrhagic Shock
As previously described, after intraperitoneal pentobarbital, a unilateral lung contusion was made by a percussive nail gun (Sears Brand, Chicago, IL) applied directly to a 12-mm metal plate that was placed in the right axilla of the rodent. 4 Ten minutes after lung contusion, the right femoral artery and internal jugular vein were cannulated using heparinized saline (10 units/mL). The femoral artery tubing was then connected to a continuous blood pressure monitoring device (BP-2 Digital Blood Pressure Monitor; Columbus Instruments, Columbus, OH) for measurement of mean arterial pressure and heart rate. Blood was then withdrawn from the internal jugular to maintain a mean arterial pressure of 30 mm Hg to 35 mm Hg for 45 minutes. After shock shed blood is reinfused.
Chronic Restraint Stress
Daily restraint stress was used to recreate CS. Rodents undergoing LCHS/CS were placed in nose cone holders (Kent Scientific Corporation, Torrington, CT) for 2 hours daily for 6 days. During the 2 hours, rodents were repositioned in the cone every 30 minutes to prevent habituation and during which an alarm sounded for 2 minutes. Rodents in the LCHS/CS model were given 24 hours to recover from the injury before starting restraint stress. Those rodents in LCHS alone model were restricted from food and water during daily restraint stress.
Spleen Erythroid Progenitor Colonies
Spleen erythroid progenitor colony growth assays, including colony-forming units-granulocyte-, erythrocyte-, monocytemegakaryocyte (CFU-GEMM), burst-forming unit-erythroid (BFU-E), and colony-forming unit-erythroid (CFU-E), were performed. The spleen was shredded and placed through a 70-μm filter over a plate containing 1 mL Iscove's Modified Dulbecco's Medium. The sample was then collected, counted, and a solution of spleen mononuclear cells was prepared to yield a concentration of 20 Â 10 6 cells/mL in Iscove's Modified Dulbecco's Medium. Cells were plated in duplicate (1 Â 10 6 per plate) with Methocult media (Stemcell, Vancouver, BC, Canada). Plates were further supplemented with 1.3 U/mL rhEpo and 6 U/mL rhIL-3 for BFU-E and CFU-E or 3 U/mL rhGM-CSF for CFU-GEMM. Plates were then incubated at 37°C in 5% CO 2 incubator. A blinded reader assessed colony growth of CFU-E on day 7, BFU-E colonies on day 14, and CFU-GEMM colonies on day 17.
Flow Cytometry
Cell suspensions from harvested spleens were prepared as described above. 1 Â 10 6 cells/mL were stained to identify HPCs that were counted by flow cytometry using CD-71 and c-kit (CD-117) antibodies. CD-71, also known as transferrin receptor-1, is a marker for one of the earliest erythroid progenitor cells precursors, BFU-E cells. 24 C-kit, also known as CD 117, is a receptor also expressed on early progenitor cells, such as CFU-GEMM, BFU-E, and CFU-E. 25 Briefly, spleen cells were incubated with mouse anti-rat CD71 (BD Biosciences, San Jose, CA) antibody conjugated with fluorescein isothiocyanate and rat anti-mouse CD117 (c-kit) (Southern Biotech, Birmingham, AL) antibody conjugated to phycoerythrin (BD Biosciences). Cells were also stained with a Live/Dead Fixable stain kit and DyeCycle Ruby (ThermoFisher Scientific, Waltham, MA) to evaluate for viability and cell cycle. The samples were run on BD LSR II flow cytometer equipped with FACSDiva software (BD Biosciences) to quantitate CD117 and CD71 positive proliferating cells.
Erythropoietin, Erythropoietin Receptor and BMP4 Expression
Spleen RNA were isolated used RNeasy Mini Kit (Qiagen, Germantown, MD). Complementary DNA (cDNA) was then prepared from the RNA using a cDNA reverse transcription kit (Applied Biosystems, Foster City, CA). EPO (32 cycles; annealing temperature, 50°C), EPO receptor (EPOr) (32 cycles; annealing temperature, 60°C), and BMP4 (32 cycles; annealing temperature, 56°C) polymerase chain reaction was performed using the following primers: EPO: 5-AGTCGCG-TTCTGGAGAGGTA-3, 5-TGCAGAAAGTATCCGCTG-3, EPOr: 5-GCTCCTATGACCACCCACAT-3, 5-GGTGGTGAAGAG-ACCCTCAA-3, and BMP4: 5-TGATACCTGAGACCGGGAAG-3, 5-TCCTCACAGTGTTTGGCTCTG-3. The following β-actin primers (annealing temperature 60°C) were used: 5-AGCCATG-TACGTAGCCATCC-3,5-CTCTCAGCTGTGGTGGTGAA-3.Amplified bands were visualized with 1.5% agarose gels, and densitometry was measured using Image Processing and Analysis (ImageJ-NIH, Bethesda, MD).
Hemoglobin Analysis
Heparinized blood samples were used for the analysis of hemoglobin levels using a VetScan HM5 Hematology Analyzer (Abaxis, CA).
Statistical Analysis
Graph Pad Prism Version 6 (San Diego, CA) was used to perform all statistical analyses. All data were presented as mean ± standard deviation. Normally distributed variables were compared using t tests, whereas Mann-Whitney U test was used to compare all other variables. Significance was defined as *p < 0.05 versus naive controls and **p < 0.05 vs. untreated counterpart.
RESULTS
Impact on Spleen Weight
Seven days after LCHS alone, spleen weight was similar to naïve animals (Fig. 1A) . However, the addition of CS to LCHS significantly increased weight by 29% (**p = 0.015) versus LCHS ( Fig. 2A) .
Impact on Spleen Erythroid Progenitor Colony Growth
Spleen erythroid progenitor colony growth was assessed to evaluate erythropoiesis occurring in the spleen. On day 7, there were no significant differences in spleen CFU-GEMM, BFU-E, and CFU-E erythroid progenitor colonies after LCHS in comparison to naive (Fig. 1B-D) . LCHS/CS increased growth of spleen CFU-GEMM, BFU-E, and CFU-E colonies as compared with naive animals. The addition of CS to LCHS increased spleen CFU-GEMM, BFU-E, and CFU-E colony growth by 49%, 61%, and 34%, respectively (**p = 0.0002, **p = 0.0163, **p = 0.0163) when compared with LCHS alone (Fig. 1B-D) .
HPCs in the Spleen
The addition of CS to LCHS increased the percent of CD71/CD117 double positive HPCs in the peripheral blood ninefold in comparison to naive and LCHS rodents ( Fig. 2A) . In the spleen, on day 7, LCHS increased the percent of CD71/ CD117 double positive splenic HPCs from 0.60% to 0.96% compared with naive animals (Fig. 2B) . With the addition CS to LCHS, the percent of CD71/CD117 double positive splenic HPCs increased 88% when compared with naive animals (LCHS/CS, 1.13 ± 0.5 vs. naive, 0.60 ± 0.50) (Fig. 2B) . After LCHS and LCHS/CS, 64% and 70% of splenic HPCs detected were actively proliferating cells (Fig. 2C ).
Impact on Splenic BMP4, EPO, and EPOr Expression
In the spleen, stress erythropoiesis requires BMP4 to differentiate immature erythroid progenitor cells into erythroblasts. 20 Seven days after LCHS, spleen BMP4 expression was similar to naïve (Fig. 3) . With the addition of daily CS to LCHS, we demonstrated enhanced expression of BMP4. LCHS/CS BMP4 expression increased 18% compared with naive rodents (Fig. 3) .
LCHS alone did not cause any significant changes in splenic EPO or EPOr expression (Figs. 4A and B) . Seven days after LCHS/CS, EPO expression increased 23% (Fig. 4A) , whereas there was significant suppression of EPOr expression (27 ± 5** vs. 42 ± 6, p = 0.0077) compared with LCHS alone (Fig. 4B) . Despite evidence of splenic erythropoiesis, 7 days after LCHS/CS, there was a persistent injury-associated anemia with a hemoglobin of 10.8 ± 0.8 g/dL (Fig. 4C ). There was no significant change in the number of circulating red blood cells (LCHS, 6.1 ± 0.7 vs. LCHS, 6.0 ± 0.5 Â 10 12 /L).
DISCUSSION
After severe trauma, critically injured patients develop a persistent injury-associated anemia within a week of hospitalization that can last for months. 26, 27 Although the etiology of persistent injury-associated anemia is complex and multifactorial, previous studies have demonstrated that hypercatecholaminemia associated with severe injury suppressed bone marrow erythroid colony growth and resulted in prolonged HPC mobilization. 3, 5 Currently, there are no data on the role of extramedullary erythropoiesis after severe traumatic injury. This is the first study to establish that after LCHS and CS extramedullary erythropoiesis occurs in the spleen as demonstrated by increased spleen weight, splenic erythroid progenitor colony growth, splenic HPCs, BMP4, and EPO expressions. This study also demonstrated decreased expression of splenic EPOr and despite evidence of extramedullary erythropoiesis, a persistent injury-associated anemia remained.
Increased splenic erythroid colony growth and EPO are necessary for extramedullary erythropoiesis. 22, 23, 28 Inra et al. 23 demonstrated that mice injected with cyclophosphamide and granulocyte colony stimulating factor to induce HPC mobilization had increased extramedullary erythropoiesis with increased spleen size and splenic erythroid progenitor cell growth, including growth of CFU-GEMM and BFU-E. Bennett et al. 14 also demonstrated that severely anemic mice develop significantly enlarged spleens, three to four times the number of cells compared with naive mice and splenic erythroid progenitor cell colony growth increased 20 times compared with normal spleens. In this study, 7 days after LCHS with daily CS, there was a significant increase in spleen weight as well as splenic erythroid colony growth. This study demonstrated the importance of stress after traumatic injury and the addition of CS after LCHS was key to the activation of extramedullary erythropoiesis which was not seen in rodents subject to LCHS alone. The initial sympathetic response after trauma is a necessary physiologic response, but when this stressful state is prolonged, it impacts many organs. This finding is supported by the work of Vignjević et al. 29 who demonstrated that psychological stress alone activates extramedullary erythropoiesis in adult mice.
In periods of homeostasis when HPCs mobilize from the bone marrow, they tend to migrate to sites of erythropoiesis, such as the spleen. 9 However, after trauma, we previously demonstrated that HPCs (CD71-and CD117-positive cells) mobilize from the bone marrow to the peripheral blood and to sites of injury to aid in tissue repair. 4 This prolonged HPC mobilization after injury was associated with decreased bone marrow cellularity and decreased bone marrow erythroid colony growth. 6 In this study, the addition of CS to LCHS increased splenic HPCs on day 7. This is similar to work by Perry et al. 28 where phenylhydralazine-induced anemic mice increased late splenic HPCs (Ter119 positive cells), a marker for mature erythroid cells. Yet, CS alone in mice did not increase the total number of Ter119 positive cells after 7 days. 29 It took 14 days of restraint stress to increase the number of Ter119 positive cells, suggesting that CS led to a delay in terminal erythroid differentiation. 29 This confirms that extramedullary erythropoiesis in the spleen works rapidly to produce mature erythroid cells. Similarly, in our model of LCHS/CS, 70% of the HPCs in the spleen were viable and proliferating cells, suggesting that the majority of HPCs in the spleen are maturing.
Previous work has demonstrated that extramedullary erythropoiesis is activated by acute anemia as a rapid response to HPC mobilization and a need for mature red blood cells. 22 In the spleen during extramedullary erythropoiesis, HPCs differentiate to BFU-E cells in the presence of BMP4 and EPO. 20 In this study, we found that the expression of BMP4 in the spleen is increased after LCHS/CS. Millot et al. 20 demonstrated that anemic mice who received combined zymosan and EPO injections had a fourfold increase in spleen BMP4 expression. Both the combination of EPO and a proinflammatory state played a role in the increased expression of BMP4 and erythroblast maturation in the spleen. 20 In the bone marrow, EPO and its receptor, EPOr, are vital for the maturation of BFU-E and CFU-E to proerythroblasts. 30 However, splenic BFU-Es have the capability to mature in the presence of EPO alone. 22 Previous work by Lenox et al. 22 demonstrated that splenic BFU-Es in phenyl-hydralazine induced anemic mice grew two to three times more with EPO alone as compared to bone marrow BFU-Es. Bone marrow exposed to only EPO formed very few BFU-Es. 22 Likewise, our current work demonstrated that 7 days after LCHS/CS, spleen EPO expression increased, and splenic BFU-Es had the most significant colony growth as compared with CFU-GEMM and CFU-E. There is growing evidence that splenic erythroid progenitors are distinct from those in the bone marrow. 22 Further analysis of extramedullary erythropoiesis has demonstrated decreased expression of splenic EPOr after LCHS/CS. This is supported by findings of decreased EPOr and glucocorticoid receptor expression in the spleen after chronic psychological stress. 29 The glucocorticoid receptor cooperates with EPOr to enhance the proliferation of splenic erythroid progenitors, demonstrating the importance of sympathetic activation in this process.
After LCHS/CS, anemia persisted regardless of elevated splenic EPO expression and increased extramedullary erythropoiesis in the spleen. This finding is supported by Bennett et al. 14 and Millot et al. 20 where mice remained anemic despite evidence of extramedullary erythropoiesis. The reduced hemoglobin after LCHS/CS may be the result of a low level of circulating iron. 31 Hepcidin sequesters iron within macrophages preventing the maturation of red blood cells. In addition, although iron deficiency is associated with an increased rate of erythropoiesis, erythroid precursors have been shown to proliferate and then become quiescent without completing the maturation cycle. 32 The lack of improvement in anemia may also be related to the severity of bone marrow dysfunction caused by LCHS/CS. The burden of producing mature functional erythrocytes and restoring hemoglobin levels may exceed the capacity of the spleen after severe trauma and CS. Although extramedullary erythropoiesis does not provide enough mature erythrocytes to improve anemia after LCHS/CS, it does provide insight on the erythropoietic response after injury.
In conclusion, CS after LCHS activated extramedullary erythropoiesis in the spleen leading to increased splenic weight, increased splenic erythroid progenitor colony growth, and increased proliferating splenic HPCs. In addition, the splenic expression of EPO and BMP4 were associated with extramedullary erythropoiesis. Additional studies are needed to examine the connection between persistent injury-associated anemia and extramedullary erythropoiesis to further delineate the impact of CS on the erythropoietic response after trauma. Extramedullary erythropoiesis may play a key role in identifying new therapies to aid the recovery from acute anemia after severe trauma and CS. 
